Press Releases

ITUS Subsidiary Anixa Diagnostics Corporation Appoints Dr. Michael Shepard to Its Scientific Advisory Board

December 7, 2015

ITUS Subsidiary Anixa Diagnostics Corporation Announces Initial Cancer Biomarker Results

October 5, 2015

ITUS Subsidiary Anixa Diagnostics Enters Into Collaborative Research Agreement With The Wistar Institute, a Leading Cancer Research Institute

July 14, 2015

ITUS Announces Uplisting to NASDAQ

July 9, 2015

ITUS Announces Reverse Stock Split With the Intention to List Shares on NASDAQ

June 25, 2015

ITUS Announces Formation of Cancer Diagnostics Subsidiary

June 23, 2015

ITUS Releases Operating Results for Fiscal 2014

January 29, 2015

Latest News & Events

Feb 13, 2019

Anixa Biosciences to Present at Moffitt Cancer Center's Business of Biotech Conference

Read More...

Jan 25, 2019

Anixa Biosciences Conference Call Recording Available on Company Website

Read More...

Jan 24, 2019

Anixa Biosciences CAR-T Cancer Therapy Patent Receives Notice of Allowance

Read More...

Cancer Fact: Liver cancer accounts for 3.6% of worldwide cancer incidences.